BioCentury | Apr 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

...protein PorA (N. meningitidis porA) Chimeric antigens against N. meningitidis porA and N. meningitidis factor H binding protein (N. meningitidis fHbp...
BioCentury | Mar 27, 2018
Distillery Therapeutics

Infectious disease

...INDICATION: Bacterial infection Chimeric antigens against N. meningitidis fHbp and N. meningitidis porA could be used...
...serogroup B N. meningitidis infection. The antigens were generated by using a soluble N. meningitidis fHbp...
...epitope of N. meningitidis porA and deleting a single amino acid from the N. meningitidis fHbp...
BioCentury | Mar 31, 2016
Distillery Techniques

Techniques: Bacteria-derived, sheath-like nanoparticles for antigen delivery in infectious disease vaccines

...clinical isolate of Neisseria meningitidis, sera from mice immunized with sheaths fused to N. meningitidis factor H binding protein ( fHbp...
BioCentury | Aug 4, 2011
Distillery Techniques

Technology: Drug platforms

...A recombinant Neisseria meningitidis factor H-binding protein (fHBP)-based vaccine for broad protective immunity A recombinant fHBP-based... a murine bactericidal activity assay and further optimized by fusing two copies of the fHBP...
BioCentury | Feb 26, 2009
Distillery Therapeutics

Indication: Infectious disease

...and contact information Infectious disease Meningitis Complement factor H (CFH); genome-derived neisserial antigen 1870 (GNA1870; fHbp...
Items per page:
1 - 5 of 5